COVID-19 vaccination in Canada
Information on COVID-19 doses distributed, doses administered and vaccination coverage.
Changes to update schedule
Please note that due to the holidays, the May 27 report will be published on May 30, 2022.
Doses administered
This page provides information on the number of COVID-19 vaccine doses that have been administered in Canada by jurisdiction, dose number and vaccine product. The number of vaccine doses administered is not the same as the number of people vaccinated.
We update information on the number of COVID-19 doses administered across Canada at different times:
- Key updates and updates from provincial and territorial websites are updated every weekday
- Reports from provinces and territories are updated every second Friday at noon Eastern Time with data up to and including the previous Sunday.
On this page
- Key updates
- About COVID-19 vaccines and vaccination
- Doses administered: updates from provincial and territorial websites
- Doses administered: reports from provinces and territories New
- Suggested citation
Key updates as of {MMM DD, YYYY}
We update this number every weekday. Most provinces and territories do not update their numbers every day (see data sources). Information is subject to change and may differ from provincial and territorial reports (see limitations).
As most jurisdictions have reduced or stopped their regular update on doses administered on their website, the information on the number of doses administered the previous day has been removed.
About COVID-19 vaccines and vaccination
Vaccination programs, primary series and booster doses
Vaccination programs
- COVID-19 vaccination began in Canada on December 14, 2020.
- 7 COVID-19 vaccines are currently approved for use in Canada.
- The COVISHIELD version of the AstraZeneca vaccine is no longer used in Canada as the interim order for its use expired on September 16, 2021.
- The National Advisory Committee on Immunization’s (NACI) recommendations on the use of COVID-19 vaccines can be found in the latest NACI statements.
- People 5 years and older without contraindications to the vaccine are currently eligible for COVID-19 vaccination.
Primary series
- 2-dose vaccines: Pfizer-BioNTech Comirnaty® (two formulations, one for those aged 12 and older and another one for those aged 5 to 11 years), Moderna Spikevax® (6 to 11 years and 12 and older), AstraZeneca Vaxzevria® (18 and older), Novavax Nuvaxovid® (18 and older) and Medicago Covifenz® (18 to 64).
- People who have received only 1 dose are considered partially vaccinated.
- People who have received both doses are considered fully vaccinated.
- Moderately to severely immunocompromised people who have received an additional dose of an mRNA vaccine are considered fully vaccinated.
- 1-dose vaccine: Janssen (18 and older)
- People who have received only 1 dose are considered fully vaccinated.
- Moderately to severely immunocompromised people who have received an additional dose of an mRNA vaccine are considered fully vaccinated.
Booster doses
NACI recommends a booster dose of an mRNA vaccine or Novavax Nuvaxovid® at least 6 months after the primary series is completed for members of the following populations.
- A booster should be offered to:
- adults 18 years of age and older
- adults living in long-term care homes for seniors or other congregate living settings that provide care for seniors
- people who completed their series with only viral vector vaccines (the AstraZeneca Vaxzevria/COVISHIELD or Janssen COVID-19 vaccines)
- adults in or from First Nations, Inuit, and Métis communities
- all frontline health care workers who have direct in-person contact with patients
- adolescents 12 to 17 years of age:
- with an underlying medical condition at high risk of severe illness due to COVID-19 (including those who are immunocompromised and who received a 3-dose primary series)
- who are residents of congregate living settings (e.g., shelters, group homes, quarters for migrant workers, correctional facilities)
- who belong to racialized and/or marginalized communities disproportionately affected by COVID-19
- A booster may be offered to:
- adolescents 12 to 17 years of age
NACI recommends that jurisdictions prepare for the rapid deployment of a second COVID-19 vaccine booster dose program over the coming weeks prioritizing the certain populations.
Local information
For local information on doses administered, please see your province’s or territory’s COVID-19 vaccination website.
Doses administered: updates from provincial and territorial websites Access and download the national COVID-19 vaccine administration data in .csv format
Altogether, {Total doses administered} vaccine doses have been administered as of {MMM DD, YYYY}.
Figure 1. Cumulative number of COVID-19 vaccine administered in Canada by jurisdiction, as of DD MMM YYYY HH PM
Hover over or select a portion of the map to see the cumulative number of COVID-19 vaccine doses administered in Canada and each jurisdiction over time.
Note: This information is based on the most current data available at the time of reporting. Green bars indicate the reported cumulative number of doses administered as of that date while grey bars are used for days where no data was reported. Due to differences in when provincial and territorial partners update their data, comparisons over time and between provinces and territories should be interpreted with caution (see data sources). Information is subject to change and may differ from provincial and territorial reports depending on when data is updated (see limitations).
Figure 1: Text description
Cumulative number of COVID-19 vaccine doses administered in Canada by jurisdiction as of MMM DD, YYYY
Doses administered: reports from provinces and territories Access and download the national COVID-19 vaccine administration databy dose number and report week in .csv format
Information on doses administered by dose number and vaccine product is provided by provinces and territories every 2 weeks.
- In the last 2 weeks, the majority of doses administered were dose 4 or more.
Figure 2. Number of COVID-19 vaccine doses administered in every 2 weeks by dose number, MMM DD, YYYY
Hover over or select a bar to see the number of doses administered by dose number and report week.
Figure 2. Number of COVID-19 vaccine doses administered in Canada every 2 weeks by dose number and jurisdiction, {MMM DD, YYYY}
Figure 2: Text description
Table 1. Cumulative number of COVID-19 vaccine doses administered in by vaccine product and dose number, as of MMM DD, YYYY
Vaccine product | Total doses | Dose 1 | Dose 2 | Dose 3 | Dose 4 | Dose 5+ |
---|
Figure 3. Cumulative number of COVID-19 vaccine doses administered in by vaccine product and dose number, as of MMM DD, YYYY Access and download the national COVID-19 vaccine administration databy dose number and report week in .csv format
Hover over or select a bar to see the cumulative number of doses administered by dose number and vaccine product. Click on a legend element to add or remove the corresponding bars from the graph.
Figure 3. Cumulative number of COVID-19 vaccine doses administered in Canada by vaccine product and dose number, as of MMM DD, YYYY
Figure 3: Text description
Week ending | Jurisdiction | Vaccine product | Total doses | Dose 1 | Dose 2 | Dose 3 | Dose 4 | Dose 5+ |
---|
Suggested citation
Public Health Agency of Canada. Canadian report on COVID-19 vaccine doses administered. Ottawa: Public Health Agency of Canada; MMM DD, YYYY. https://health-infobase.canada.ca/covid-19/vaccine-administration/
Related links
- Vaccines for COVID-19
- Vaccine distribution
- Reported side effects following COVID-19 vaccination in Canada
- COVID-19 daily epidemiology update: Cases following vaccination
- COVID-19: Effectiveness and benefits of vaccination
- COVID-19 Vaccination Coverage Survey (CVCS)
- COVID-19 vaccine uptake and intent: Canadian Community Health Survey (CCHS) insight
- Canada's COVID-19 immunization plan
- The facts about COVID-19 vaccines
- Vaccines for children
- Ask the experts video series: COVID-19 vaccines questions
For health professionals
- COVID-19 information for health professionals
- National Advisory Committee on Immunization (NACI)
- COVID-19 daily epidemiology update
Provincial, territorial and other federal COVID-19 vaccination webpages
- British Columbia
- Alberta
- Saskatchewan
- Manitoba
- Ontario
- Quebec
- Newfoundland and Labrador
- New Brunswick
- Nova Scotia
- Prince Edward Island
- Yukon
- Northwest Territories
- Nunavut
- Indigenous Services Canada
- Correctional Service Canada
- Date modified: